Koning Corporation
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Koning Corporation - overview
Established
2002
Location
Norcross, GA, US
Primary Industry
Medical Devices & Equipment
About
In 2002, the company was founded by Lutao Ning, a biomedical engineering background entrepreneur, through acquiring a license from University of Rochester. In 2006, the company's first clinical trials for KBCT prototype was carried out. In 2008, the company raised USD 4 million in series A round of financing from Sansar Capital. In 2014, the company raised USD 12 million in series B round of funding from Dingxin Capital.
In 2017, KBCT was commercialized via approval from FDA. In 2008, KBCT was approved by regulatory officials from Canada, Singapore, Australia, Thailand, Qatar, and China. In 2022, one year later after the company announced its series C round was open, another USD 2. 6 million was raised.
The company's main product is called KBCT (Koning's Breast CT, or Koning Vera Breast CT), a breast cancer scanner, which can produce 3D images, can replaces multiple procedures including MRI, stereotactic biopsy, and FFDM/DBT. The company plans to deploy fund into business expansion in China and the US, and to develop a smaller, lower cost device.
Current Investors
Sansar Capital, Dingxin Capital
Primary Industry
Medical Devices & Equipment
Sub Industries
Healthcare, Medical Devices & Equipment
Website
www.koninghealth.com
Company Stage
Series B
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.